Navigation Links
FAAN Names New CEO

FAIRFAX, Va., Dec. 1 /PRNewswire-USNewswire/ -- The Food Allergy & Anaphylaxis Network (FAAN) today named Julia E. Bradsher, Ph.D., as its new CEO, replacing Founder Anne Munoz-Furlong, who is retiring.

Dr. Bradsher brings to FAAN extensive knowledge of anaphylaxis, a severe, potentially fatal allergic reaction. For the past six years, as Senior Director of Marketing, she led the marketing team and strategic planning for all Dey Pharmaceutical products, including EpiPen(R), an autoinjector device containing epinephrine, a drug that can stop an anaphylactic reaction. In that role, she has dealt extensively with leaders in the allergy-related scientific community. She has also conducted research on the needs of those who suffer from food allergy and anaphylaxis.

Frank Yiannas, FAAN's Chairman of the Board, said, "Julia's background in the treatment of anaphylaxis, her knowledge of the allergy community, and her passion for protecting food-allergic individuals are what made her an ideal candidate for this position. She is well positioned to help set FAAN's strategic agenda for the next five years."

Hugh Sampson, M.D., FAAN's Medical Director, said, "Julia's background in health policy and administration, her understanding of anaphylaxis and its effects on patients and their families, and her appreciation of the history and culture of FAAN make her an ideal candidate to lead the organization over the coming years. With Julia, our patients' welfare and scientific accuracy will remain at the forefront of FAAN's mission."

Bradsher holds a Ph.D. in medical sociology from the University of Miami and a master's in business administration from the Sawyer School of Management at Suffolk University in Boston. She has authored 10 journal articles, seven book chapters, and other solicited publications, and she has held research and faculty appointments in private research institutes and universities.

Anne Munoz-Furlong, FAAN's Founder and CEO for its first 18 years, said, "We have been searching for someone who can provide the intellectual leadership and the compassion for the families affected by food allergy and anaphylaxis. Julia has both and will lead FAAN into the next phase of its growth."


Founded in 1991, the Food Allergy & Anaphylaxis Network (FAAN) is the world leader in information about food allergy, a potentially fatal condition that afflicts about 12 million Americans, or one out of every 25. A nonprofit organization based in Fairfax, Va., FAAN has 30,000 members in the U.S., Canada, and 62 other countries. It is dedicated to increasing public awareness of food allergy and its consequences, to educating people about the condition, and to advancing research on behalf of all those affected by it. FAAN provides information and educational resources about food allergy to patients, their families, schools, health professionals, pharmaceutical companies, the food industry, and government officials. For more information, please visit FAAN at,, and

    CONTACT: Jennifer Love
    Marketing and Media Communications Manager
    The Food Allergy & Anaphylaxis Network
    703-563-3061 direct
    301-639-4811 cell

SOURCE Food Allergy & Anaphylaxis Network
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
2. Mediware Names Thomas K. Mann Chief Executive Officer
3. Cleveland-based Health Care Tech Company Within3 Names New CEO
4. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
5. Patient Safety Authority Board of Directors Names Infection Advisory Panel
6. Hooper Holmes Names Chris Behling President of Health & Wellness Division
7. MDMA Names New Director of Federal Affairs
8. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
9. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
10. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
11. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... has prided itself for not only fulfilling the needs of advisers and clients ... an affordable price and providing top-tier customer service. However, there's always room for ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... CBD ... Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography ... CAAHEP accredited colleges, as only one of twelve colleges and universities in the state ...
(Date:11/27/2015)... ... , ... Dr. Thomas Dunlap and Dr. Patrick Coleman , ... Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , co-hosted ... similar ways and require time-critical intervention to avoid large area heart damage and progressive ...
(Date:11/27/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the ... LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making the ... a version of Asterisk that will receive not only security fixes, but feature ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... WASHINGTON , Nov. 25, 2015  The ... Obstetricians and Gynecologists (ACOG), and the March of ... bipartisan Protecting Our Infants Act of 2015 ... the number of newborns born exposed to drugs, ... Since the bill,s introduction, all three organizations have ...
(Date:11/25/2015)... 2015 On Tuesday, November 24, 2015, ... against Wright Medical Technology, Inc. for product liability ... hip implant device, awarded $11 million in favor ... trial and three days of deliberations, the jury ... defectively designed and unreasonably dangerous, and that Wright ...
(Date:11/25/2015)... Kitov Pharma ceuticals ... biopharmaceutical company focused on the development of therapeutic candidates ... announced the closing of its previously announced underwritten public ... each representing 20 ordinary shares of the Company, and ... and warrants were issued in a fixed combination of ...
Breaking Medicine Technology: